On the other hand, another study showed that one year of high-dose vitamin D supplementation did not significantly alter serum IGF-1 among women at a high risk of breast cancer [34] nor in prediabetes subjects [35]. The gene discussed is IGF1; the disease is prediabetes syndrome.